N-(3-(Benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(2,4-dichlorophenoxy)acetamide hydrochloride

Catalog No. :
ACCXBU709
CAS No. :
1216749-78-8
Molecular Formula :
C29H24Cl3N3O2S2
Molecular Weight :
617.02

IUPAC Name:N-(3-(benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(2,4-dichlorophenoxy)acetamide hydrochloride

N-(3-(Benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(2,4-dichlorophenoxy)acetamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(Benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(2,4-dichlorophenoxy)acetamide hydrochloride
IUPAC NameN-(3-(benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(2,4-dichlorophenoxy)acetamide hydrochloride
Molecular FormulaC29H24Cl3N3O2S2
Molecular Weight617.02
SMILESO=C(NC(S1)=C(C2=NC3=CC=CC=C3S2)C4=C1CN(CC5=CC=CC=C5)CC4)COC6=CC=C(Cl)C=C6Cl.[H]Cl
InChI KeyDBDVHDHUDHTOLM-UHFFFAOYSA-N
SynonymN-(3-(benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(2,4-dichlorophenoxy)acetamide hydrochloride
CAS No.1216749-78-8

Synthetic Route by SureRoute

1. ACCXBU709 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCXBU709 route product structure diagram
    ACCXBU7091216749-78-8
Inquiry

2. ACCXBU709 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCXBU709 route product structure diagram
    ACCXBU7091216749-78-8
Inquiry

Comments (0)